Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepatitis × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 72 Precursor Cell Lymphoblastic Leukemia-Lymphoma 62 Myelodysplastic Syndromes 61 Leukemia, Lymphocytic, Chronic, B-Cell 61 Lymphoma, Non-Hodgkin 55 Hodgkin Disease 53 Leukemia 47 Multiple Myeloma 45 Lymphoma, Follicular 39 Lymphoma 38 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38 Lymphoma, Mantle-Cell 37 Lymphoma, Large B-Cell, Diffuse 36 Lymphoma, B-Cell, Marginal Zone 35 Myeloproliferative Disorders 31 Burkitt Lymphoma 31 Congenital Abnormalities 26 Lymphoma, Large-Cell, Immunoblastic 24 Leukemia, Myelomonocytic, Chronic 24 Leukemia, Myeloid, Chronic-Phase 22 Hematologic Neoplasms 22 Waldenstrom Macroglobulinemia 20 Leukemia, Myeloid, Accelerated Phase 19 Primary Myelofibrosis 18 Neoplasms, Plasma Cell 18 Leukemia, Prolymphocytic 18 Anemia, Refractory, with Excess of Blasts 18 Recurrence 17 Graft vs Host Disease 17 Dendritic Cell Sarcoma, Interdigitating 17

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡